Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia ; volume:8 ; number:1 ; day:30 ; month:1 ; year:2019 ; pages:1-14 ; date:12.2019
Experimental hematology & oncology ; 8, Heft 1 (30.1.2019), 1-14, 12.2019
- Urheber
-
Niparuck, Pimjai
Limsuwanachot, Nittaya
Pukiat, Sulada
Chantrathammachart, Pichika
Rerkamnuaychoke, Budsaba
Magmuang, Sutada
Phusanti, Sithakom
Boonyawat, Kochawan
Puavilai, Teeraya
Angchaisuksiri, Pantep
Ungkanont, Artit
Chuncharunee, Suporn
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-019-0127-z
- URN
-
urn:nbn:de:101:1-2019030422315573363808
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Niparuck, Pimjai
- Limsuwanachot, Nittaya
- Pukiat, Sulada
- Chantrathammachart, Pichika
- Rerkamnuaychoke, Budsaba
- Magmuang, Sutada
- Phusanti, Sithakom
- Boonyawat, Kochawan
- Puavilai, Teeraya
- Angchaisuksiri, Pantep
- Ungkanont, Artit
- Chuncharunee, Suporn
- SpringerLink (Online service)
Ähnliche Objekte (12)
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
RSK1 dependency in FLT3-ITD acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation
The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia
Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia